New drug screening technologies transferring to overseas
The Korea Health Industry Development Institute (KHIDI) announced that the screening system technologies for the development of new drugs owned by Tolgene, a bio engineering venture company of Korea, ha...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
